Alternate Text DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.

Belizatinib(TSR-011)

  Cat. No.:  DC10448   Featured
Chemical Structure
1357920-84-3
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Belizatinib(TSR-011) is an orally available inhibitor of both the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the tropomyosin-related kinases (TRK) TRKA, TRKB, and TRKC, with potential antineoplastic activity.
Cas No.: 1357920-84-3
Chemical Name: Belizatinib
Synonyms: Belizatinib;TSR-011;Belizatinib (TSR011);Z8A6022P3J;Belizatinib [INN];4-fluoro-N-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-1-((1s,4s)-4-(isopropylcarbamoyl)cyclohexyl)-1H-benzo[d]imidazol-2-yl)benzamide;4-Fluoro-N-{(2e)-6-{[4-(2-Hydroxypropan-2-Yl)piperidin-1-Yl]methyl}-1-[cis-4-(Propan-2-Ylcarbamoyl)cyclohexyl]-1,3-Dihydro-2h-Benzimidazol-2-Ylidene}benzamide;4-fluoro-N-(6-((4-(2-hydroxypropan-2-yl)piperidin-1-yl)methyl)-
SMILES: FC1C([H])=C([H])C(=C([H])C=1[H])C(N([H])C1=NC2C([H])=C([H])C(=C([H])C=2N1C1([H])C([H])([H])C([H])([H])C([H])(C(N([H])C([H])(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])C1([H])[H])C([H])([H])N1C([H])([H])C([H])([H])C([H])(C(C([H])([H])[H])(C([H])([H])[H])O
Formula: C33H44FN5O3
M.Wt: 577.7326
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Belizatinib is an oral, dual, potent inhibitor of ALK and TRKA, TRKB, and TRKC, with IC50 of 0.7 nM for wild-type recombinant ALK kinase.
In Vivo: TSR-011 exerts sustained potent inhibition of ALK-dependent tumour growth in mouse models[1].
In Vitro: TSR-011 has antitumour activity in the clinical trials.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC9837 Larotrectinib (LOXO-101 sulfate) LOXO-101 is a small molecule that was designed to block the ATP binding site of the TRK family of receptors, with 2 to 20 nM cellular potency against the TRKA, TRKB, and TRKC kinases.
DC10448 Belizatinib(TSR-011) Belizatinib(TSR-011) is an orally available inhibitor of both the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the tropomyosin-related kinases (TRK) TRKA, TRKB, and TRKC, with potential antineoplastic activity.
X